Morepen Laboratories Limited (NSE:MOREPENLAB)
48.47
-0.37 (-0.76%)
Oct 27, 2025, 3:30 PM IST
Morepen Laboratories Revenue
Morepen Laboratories had revenue of 4.30B INR in the quarter ending June 30, 2025, a decrease of -6.32%. This brings the company's revenue in the last twelve months to 18.01B, up 2.50% year-over-year. In the fiscal year ending March 31, 2025, Morepen Laboratories had annual revenue of 18.12B with 7.17% growth.
Revenue (ttm)
18.01B
Revenue Growth
+2.50%
P/S Ratio
1.48
Revenue / Employee
9.93M
Employees
1,814
Market Cap
26.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 18.12B | 1.21B | 7.17% |
| Mar 31, 2024 | 16.90B | 2.68B | 18.88% |
| Mar 31, 2023 | 14.22B | -1.34B | -8.60% |
| Mar 31, 2022 | 15.56B | 3.58B | 29.87% |
| Mar 31, 2021 | 11.98B | 3.40B | 39.57% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |
Morepen Laboratories News
- 6 weeks ago - Morepen Laboratories shares rally over 4% after company forms 50:50 Joint Venture with UAE’s Bimedical FZE - Business Upturn
- 7 weeks ago - Morepen Laboratories subsidiary to form 50:50 JV with UAE’s Bimedical FZE for medical devices business - Business Upturn
- 2 months ago - Morepen Laboratories shares drop 4% as Q1 net profit drops 68.5% YoY to Rs 11.4 crore - Business Upturn
- 2 months ago - Morepen Laboratories Q1 Results: Net profit plunges 68% YoY to Rs 11.4 crore, revenue down 6.6% YoY - Business Upturn
- 5 months ago - Morepen Laboratories secures Rs 50 crore loan facility from Qatar National Bank - Business Upturn
- 5 months ago - Morepen Laboratories share price drops 3% as Q4 Ebitda falls 12.6% to Rs 42.3 crore - Business Upturn
- 6 months ago - Morepen Laboratories receives SEC clearance for Resmetirom bioequivalence studies - Business Upturn
- 6 months ago - Morepen Labs shares rally 7% today on this major update – Know More - Business Upturn